GlaxoSmithKline - Novel FlexTab - Ownership and Business Overview

Life ScienceCompany

GlaxoSmithKline - Novel FlexTab Ownership

Who owns GlaxoSmithKline - Novel FlexTab?

GlaxoSmithKline - Novel FlexTab is owned by Capsugel Belgium NV. It was acquired on February 9, 2011.

GlaxoSmithKline - Novel FlexTab Business Overview

Where is GlaxoSmithKline - Novel FlexTab headquartered?

GlaxoSmithKline - Novel FlexTab is headquartered in United Kingdom.

What sector is GlaxoSmithKline - Novel FlexTab in?

GlaxoSmithKline - Novel FlexTab is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

GlaxoSmithKline - Novel FlexTab


United Kingdom,

GlaxoSmithKline - Novel FlexTab is a novel dosage. The FlexTab technology allows for a variety of fill materials, including powders, pellets, liquids, micro-tablets and tablets, and can even deliver separate liquid and powder API's in one dose. This innovation opens the door to novel product designs and customization options.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for GlaxoSmithKline - Novel FlexTab

Life Science Companies , United Kingdom Companies